The non-profit Hearts For Isabella was in the lead on efforts to raise more than $11,000 for a Belfast man, born with a rare ...
MSCT 增强患者长期生存 :生存分析显示,MSCT 组的 10 年总生存率显著高于对照组(89.4% vs. 73.4%, P = 0.002 )。PSM 队列分析也表明,接受 MSCT 显著降低了死亡率(10 年生存率 88.0% vs. 79.9%, P = 0.032 )。多因素 Cox 回归分析表明,MSCT 与随访期间死亡风险降低相关(HR 0.38,95% CI 0.19 - ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果